Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Black Diamond Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Biological Products, (No Diagnostic Substances)
Prev close 1.98 · gapped above the open, then crossed back over prior close. High/low 2.08 at 7:45 am ET, 1.95 at 11:00 am ET.
Black Diamond Therapeutics, Inc. has 3 disclosed suppliers and 1 disclosed customer. Each one is named in an SEC filing, either Black Diamond Therapeutics, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“On November 14, 2022, we entered into an Open Market Sale Agreement SM (the Sales Agreement) with Jefferies LLC (Jefferies), as sales agent, to provide for the issuance and sale by us of up to $150.0 million of our common stock, or the Shares, from time to time through Jefferies as our sales agent (the ATM Program).”
FILING10-K0001701541-26-000009cik 0001701541
“Under the Servier Agreement, we granted to Servier a worldwide license to develop and commercialize BDTX-4933.”
FILING10-K0001701541-26-000009cik 0001701541
“A Phase 0/1 "window of opportunity" study sponsored by the Ivy Brain Tumor Center in Phoenix, Arizona in patients with recurrent high-grade glioma (HGG) with EGFR alterations and/or fusions at initial diagnosis demonstrated that silevertinib exceeded the pre-specified threshold for drug concentration in the brain tumor tissue and was generally well tolerated.”
FILING10-K0001701541-26-000009cik 0001701541
“Based upon real-world evidence gathered in collaboration with Guardant Health, these patients have significant unmet medical needs.”
FILING10-K0001701541-26-000009cik 0001701541
Watchlist prices, news filtered to it, and its next report on your desk.
BDTX (Black Diamond Therapeutics, Inc.) has 3 disclosed suppliers and 1 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: GH +3.97%, in healthcare.